IDEX Biometrics ASA
IDBA · NASDAQ
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $61 | $386 | $356 | $510 |
| % Growth | -84.1% | 8.4% | -30.2% | – |
| Cost of Goods Sold | $1,546 | $234 | $3,609 | $4,242 |
| Gross Profit | -$1,485 | $153 | -$3,253 | -$3,732 |
| % Margin | -2,423.3% | 39.5% | -912.9% | -731.2% |
| R&D Expenses | $1,422 | $635 | $571 | -$252 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,228 | $2,539 | $1,887 | $2,202 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $2,972 | $0 | $7 |
| Operating Expenses | $2,651 | $6,147 | $2,458 | $1,942 |
| Operating Income | -$4,135 | -$5,994 | -$5,711 | -$5,674 |
| % Margin | -6,750% | -1,551.7% | -1,602.7% | -1,111.7% |
| Other Income/Exp. Net | $24,825 | -$695 | $519 | $428 |
| Pre-Tax Income | $20,690 | -$6,689 | -$5,191 | -$5,246 |
| Tax Expense | $6,131 | $2 | $0 | $16 |
| Net Income | $1,389 | -$6,691 | -$5,191 | -$5,262 |
| % Margin | 2,266.7% | -1,732.2% | -1,457% | -1,031% |
| EPS | 0.047 | -0.023 | -0.018 | -0.019 |
| % Growth | 306.2% | -23.9% | 2.9% | – |
| EPS Diluted | 0.046 | -0.023 | -0.018 | -0.019 |
| Weighted Avg Shares Out | 313,205 | 291,579 | 279,570 | 279,061 |
| Weighted Avg Shares Out Dil | 314,072 | 292,342 | 279,570 | 279,061 |
| Supplemental Information | – | – | – | – |
| Interest Income | $5 | $13 | $58 | $50 |
| Interest Expense | $605 | $552 | $592 | $37 |
| Depreciation & Amortization | -$380 | $1,104 | $366 | $539 |
| EBITDA | $1,616 | -$4,891 | -$4,234 | -$4,669 |
| % Margin | 2,638.3% | -1,266.2% | -1,188.2% | -914.9% |